Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/05/3073873/0/en/Recursion-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
04 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/04/3073732/0/en/Preliminary-Phase-1b-2-Data-for-REC-4881-in-Familial-Adenomatous-Polyposis-FAP-Demonstrates-Reduced-Polyp-Burden.html
28 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/28/3034602/0/en/Recursion-Provides-Business-Updates-and-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results.html
28 Feb 2025
// BLOOMBERG
https://www.bloomberg.com/news/articles/2025-02-28/ai-drug-firm-recursion-wants-to-be-the-amazon-prime-of-pharma
05 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/05/3021646/0/en/Recursion-Presents-Phase-2-Data-for-REC-994-in-CCM-in-Late-Breaking-Oral-Presentation-at-the-International-Stroke-Conference.html
09 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/09/2994128/0/en/Recursion-Reports-Interim-Phase-1-Clinical-Data-for-REC-617-Monotherapy-a-Potential-Best-in-Class-CDK7-Inhibitor-With-Encouraging-Patient-Response-and-Favorable-Tolerability.html
ABOUT THIS PAGE